T. Fukushima

发表

Multiple cardiac rhabdomyomas not associated with tuberous sclerosis in a dizygotic twins: a case report

H. Sameshima, Yuichiro Sato, Hiroyuki Tanaka, 2021, Journal of Medical Case Reports.

Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Is Required for Branching Morphogenesis in the Chorioallantoic Placenta

K. Miyazawa, N. Kitamura, G. Yamada, 2005, Molecular and Cellular Biology.

Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair

H. Kataoka, Hiroyuki Tanaka, T. Fukushima, 2018, International journal of molecular sciences.

PROCEEDINGS OF THE 12TH ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

H. Takeshima, T. Fukushima, Hiroaki Kataoka, 2009 .

Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT.

H. Takeshima, H. Kataoka, T. Fukushima, 2009, Anticancer research.

Macrophage Migration Inhibitory Factor (MIF)

Yuji Sato, S. Todo, J. Nishihira, 1996 .

Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis.

Yuji Sato, S. Todo, J. Nishihira, 2003, Annals of the New York Academy of Sciences.

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

M. Kawaguchi, H. Kataoka, Hiroyuki Tanaka, 2017, BMC Research Notes.

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells

Y. Yamashita, M. Kawaguchi, Hiroyuki Tanaka, 2022, Cancer science.

Aberrant methylation and silencing of the SPINT2 gene in high‐grade gliomas

H. Takeshima, Y. Takezaki, H. Itoh, 2018, Cancer science.

Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine

Katsuaki Sato, J. Janetka, Y. Hippo, 2019, Communications Biology.

Establishment and characterization of a new human glioblastoma cells line, NYGM

S. Nakano, H. Itoh, H. Kataoka, 2008, Human Cell.

Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells

K. Yorita, M. Kawaguchi, H. Kataoka, 2011, Cancer science.

Activation of hepatocyte growth factor activator zymogen (pro‐HGFA) by human kallikrein 1‐related peptidases

S. Mukai, H. Kataoka, Hiroyuki Tanaka, 2008, The FEBS journal.

Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo.

S. Nakano, H. Itoh, H. Kataoka, 2005, Cancer letters.

Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer‐associated fibroblasts by paracrine activation of protease‐activated receptor 2

Michael D. Johnson, Chen-Yong Lin, E. Camerer, 2017, International journal of cancer.

Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma

Y. Yamashita, M. Kawaguchi, T. Kaneuji, 2021, Human Cell.

Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.

Michael D. Johnson, A. Sawaguchi, Chen-Yong Lin, 2015, The American journal of pathology.

Epithelial and Mesenchymal Cell Biology Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial Integrity

A. Sawaguchi, N. Takeda, K. Yorita, 2011 .

Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.

K. Miyazawa, N. Kitamura, G. Yamada, 2004, Gastroenterology.

Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report

H. Takeshima, Yuichiro Sato, T. Fukushima, 2022, Journal of Medical Case Reports.

Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits

E. Chosa, Y. Asada, K. Kitamura, 2008, Arthritis research & therapy.

Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Haixia Cheng, H. Kataoka, Hiroyuki Tanaka, 2009, Cancer research.

Posterior mediastinal ganglioneuroma with peripheral replacement by white and brown adipocytes resulting in diagnostic fallacy from a false-positive 18F-2-fluoro-2-deoxyglucose-positron emission tomography finding: a case report

T. Ayabe, K. Yorita, H. Kataoka, 2014, Journal of Medical Case Reports.

Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.

M. Kaminishi, H. Esumi, Y. Seto, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice

M. Nakazato, K. Kangawa, H. Itoh, 2015, Cancer science.

Abstracts of Poster Presentations

Y. Izumi, Hiroyuki Takahashi, Tadao Tanaka, 2001, Human Cell.

Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

Chen-Yong Lin, M. Kawaguchi, H. Kataoka, 2013, Cancer science.

Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo

S. Nakano, H. Itoh, H. Kataoka, 2006, International journal of cancer.

Hepatocyte growth factor activator inhibitors (HAI‐1 and HAI‐2): Emerging key players in epithelial integrity and cancer

T. Shimomura, M. Kawaguchi, H. Kataoka, 2018, Pathology international.

Chemical Ecology of Astigmatid Mites XLI Undecane: The Sex Pheromone of the Acarid Mite Caloglyphus rodriguezi SAMSINAK (Acarina: Acaridae)

N. Mori, R. Nishida, Y. Kuwahara, 1995 .

Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model

K. Umezawa, M. Kawaguchi, H. Kataoka, 2016, Oncotarget.

Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.

H. Takeshima, K. Umezawa, K. Yorita, 2012, Neuro-oncology.

Insulin-Like Growth Factor Binding Protein-2: A Possible Regulator of Invasive Growth in Glioblastoma

H. Kataoka, T. Fukushima, 2011 .

Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.

Hiroaki Kataoka, H. Kataoka, Tsuyoshi Fukushima, 2007, Anticancer research.

Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24*

S. Nakano, T. Shimomura, H. Kataoka, 2007, Journal of Biological Chemistry.

Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers

H. Itoh, H. Kataoka, K. Chijiiwa, 2006, Gut.

UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death

H. Honda, S. Mukai, Y. Kishi, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Dickkopf‐1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth

K. Yorita, H. Kataoka, Hiroyuki Tanaka, 2009, International journal of cancer.

Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case

Tadaki Suzuki, A. Okayama, T. Fukushima, 2021, Viruses.

Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma

S. Mukai, H. Kataoka, H. Betsunoh, 2007, Cancer science.

Congenital tracheo‐esophageal transition: A previously undescribed tracheo‐esophageal malformation that showed direct transition of the trachea to the esophagus

Yoshiko Umekita, Hiroyuki Tanaka, T. Fukushima, 2021, Pathology international.

Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells

Michael D. Johnson, Chen-Yong Lin, Y. Yamashita, 2018, Oncotarget.

Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor‐1

Michael D. Johnson, Chen-Yong Lin, T. Shimomura, 2022, The FEBS journal.

Molecular Pathogenesis of Genetic and Inherited Diseases Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1 / Serine Protease Inhibitor , Kunitz Type 1 ( Hai-1 / Spint 1 ) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice

A. Sawaguchi, N. Takeda, M. Kawaguchi, 2010 .

Pericellular Activation of Peptide Growth Factors by Serine Proteases

H. Kataoka, T. Fukushima, 2018 .

Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells

Chen-Yong Lin, M. Kawaguchi, H. Kataoka, 2012, Human Cell.

Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses

E. Chosa, H. Itoh, H. Kataoka, 2008, Virchows Archiv.

Hepatocyte growth factor activator is a serum activator of single‐chain precursor macrophage‐stimulating protein

M. Kawaguchi, H. Kataoka, T. Fukushima, 2009, The FEBS journal.

RELA fusion-positive ependymoma accompanied by extensive desmoplasia: a case report

H. Kataoka, J. Hirato, T. Fukushima, 2020, Brain Tumor Pathology.

Interferon-b Inhibits Liver Metastases from Murine Colon 26 Carcinoma and its Highly Metastatic Variant

Yuji Sato, S. Todo, J. Nishihira, 2007, Surgery Today.

Loss of membrane‐bound serine protease inhibitor HAI‐1 induces oral squamous cell carcinoma cells' invasiveness

Chen-Yong Lin, Yuko Sato, K. Yorita, 2012, The Journal of pathology.

Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells

K. Yorita, M. Kawaguchi, H. Kataoka, 2009, Human Cell.

Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in Apc Min/+ mice

T. Nishida, E. Camerer, M. Kawaguchi, 2020, Cancer science.

Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice

T. Kamoto, S. Mukai, M. Fujii, 2023, Human Cell.

Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.

M. Seiki, K. Yorita, M. Kawaguchi, 2013, Cancer research.

Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells

H. Takeshima, H. Kataoka, Hiroyuki Tanaka, 2007, Human Cell.

Hepatocyte growth factor activator inhibitor type 1 ( Hai-1 / Spint 1 ) is a suppressor of intestinal tumorigenesis

M. Seiki, K. Yorita, M. Kawaguchi, 2013 .

Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells

Chen-Yong Lin, M. Kawaguchi, H. Kataoka, 2012, Human Cell.

Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium

M. Kawaguchi, T. Fukushima, Hiroaki Kataoka, 2023, FEBS open bio.

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

M. Kawaguchi, H. Kataoka, Hiroyuki Tanaka, 2017, BMC Research Notes.

Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression.

Yuji Sato, S. Todo, T. Yoshiki, 2005, International Journal of Molecular Medicine.

Cutaneous metastasis emerging during chemotherapy and progressing during immunotherapy for urothelial carcinoma

N. Terada, S. Mukai, T. Fukushima, 2021, IJU case reports.

Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report

H. Takeshima, H. Ohta, T. Kawano, 2023, Brain Tumor Pathology.